![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama... Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India. Show more
GERDAU S.A. - CONSOLIDATED INFORMATION PR Newswire SÃO PAULO, May 2, 2024 SÃO PAULO, May 2, 2024 /PRNewswire/ -- 1Q24 Highlights Adjusted EBITDA (earnings before interest, taxes, depreciation...
GERDAU S.A. - FORM 20-F PR Newswire SÃO PAULO, March 28, 2024 SÃO PAULO, March 28, 2024 /PRNewswire/ -- GERDAU S.A. hereby announces that the Form 20-F related to the fiscal year ended December...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.03 | -2.15827338129 | 1.39 | 1.5 | 1.305 | 978675 | 1.41920007 | CS |
4 | 0.11 | 8.8 | 1.25 | 1.5195 | 1.1 | 1444758 | 1.34573653 | CS |
12 | -0.24 | -15 | 1.6 | 1.928 | 1.01 | 1577912 | 1.40220999 | CS |
26 | 0.8461 | 164.642926639 | 0.5139 | 1.928 | 0.5051 | 2054709 | 1.19899928 | CS |
52 | 0.819 | 151.386321627 | 0.541 | 1.928 | 0.4126 | 2842774 | 0.95671471 | CS |
156 | -14.97 | -91.6717697489 | 16.33 | 19.37 | 0.4126 | 2815846 | 3.3864853 | CS |
260 | -30.18 | -95.6880152188 | 31.54 | 31.54 | 0.4126 | 2342850 | 8.06522594 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions